LIVN - LivaNova Q2 top-line down 4%; reiterates guidance July, 31 2019 09:39 AM LivaNova PLC LivaNova (LIVN +1.6%) Q2 results: Revenues: $277.2M (-3.6%); Cardiovascular: $172.2M (-2.4%); Neuromodulation: $104.3M (-5.8%); Other: $0.7M (+75.0%).More news on: LivaNova PLC, Healthcare stocks news, Earnings news and commentary, Read more ...